RABBIT Rheumatoid arthritis: observation of biologics therapy

RABBIT is the German register for the long-term observation of therapy with biologics, biosimilars and Janus kinase (JAK) inhibitors in adult patients with rheumatoid arthritis. The project was initiated in 2001 by the German Rheumatology Research Center (DRFZ) in coordination with the German Society for Rheumatology, the Professional Association of German Rheumatologists and the Competence Network Rheumatology. RABBIT is involved in international research and co-operates with other European registers.

The RABBIT Register is supported by a scientific advisory board and a research partner in the Rheumaliga.

The RABBIT register is supported by long-term shared funding from various manufacturers of innovative drugs. The DRFZ has full academic freedom in conducting the register and publishing the results.